The urgent need to recover MHC class I in cancers for effective immunotherapy.

•Tumor immune escape compromises the efficacy of cancer immunotherapy.•Loss of MHC class I expression is a frequent event in cancer cells.•Three tumor phenotypes determine cancer fate: escape, rejection and dormancy.•Recovery of MHC class I expression is required to improve cancer immunotherapy.